Open access · CC-BY
via OpenAlex
Using the drug-protein interactome to identify anti-ageing compounds for humans
Matías Fuentealba, Handan Melike Dönertaş, Rhianna Williams, John P. Labbadia, Janet M. Thornton, Linda Partridge
PLoS Computational Biology · 2019 · ▲ 48 citations
Abstract
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries.Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously.Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and healthspan(definition) in animal models, suggesting that there is scope for drug repurposing in humans.New bioinformatic methods to identify and prioritise potential anti-ageing compounds for humans are therefore of interest.In this study, we first used drug-protein interaction information, to rank 1,147 drugs by their likelihood of targeting ageing-related gene products in humans.Among 19 statistically significant drugs, 6 have already been shown to have pro-longevity properties in animal models (p < 0.001).Using the targets of each drug, we established their association with ageing at multiple levels of biological action including pathways, functions and protein interactions.Finally, combining all the data, we calculated a ranked list of drugs that identified tanespimycin, an inhibitor of HSP-90, as the top-ranked novel anti-ageing candidate.We experimentally validated the pro-longevity effect of tanespimycin through its HSP-90 target in Caenorhabditis elegans.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pcbi.1006639
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Fuentealba, M., Dönertaş, H.M., Williams, R., Labbadia, J.P., Thornton, J.M., & Partridge, L. (2019). Using the drug-protein interactome to identify anti-ageing compounds for humans. <em>PLoS Computational Biology</em>. https://doi.org/10.1371/journal.pcbi.1006639
Vancouver
Fuentealba M, Dönertaş HM, Williams R, Labbadia JP, Thornton JM, Partridge L. Using the drug-protein interactome to identify anti-ageing compounds for humans. PLoS Computational Biology. 2019. doi:10.1371/journal.pcbi.1006639.
BibTeX
@article{matas2019Usingt,
title = {Using the drug-protein interactome to identify anti-ageing compounds for humans},
author = {Matías Fuentealba and Handan Melike Dönertaş and Rhianna Williams and John P. Labbadia and Janet M. Thornton and Linda Partridge},
journal = {PLoS Computational Biology},
year = {2019},
doi = {10.1371/journal.pcbi.1006639},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Proceedings of the National Academy of Sciences 2019
Open access · CC-BY
A triple drug combination targeting components of the nutrient-sensing network maximizes longevity
Ove Andersen 2026
Open access · US-GOV
Methods for Assessing Nutrition, Inflammation, Kidney Function, Aging, Body Composition, and Hydration Among Older Patients - An Observational Study (MIKADO)
Nephrology Dialysis Transplantation 2016
Citation only
MP263IMPACT OF TRADITIONAL ANTIHYPERTENSIVE THERAPY ON CARDIOVASCULAR RISK MARKER - KLOTHO IN CHRONIC KIDNEY DISEASE PATIENTS
Aging Cell 2018
Open access · CC-BY
A salicylic acid derivative extends the lifespan of Caenorhabditis elegans by activating autophagy and the mitochondrial unfolded protein response
University of Nottingham 2021
Open access · US-GOV
Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle.
PubMed 2016
Preprint